Cargando…
Stem cell programs in cancer initiation, progression, and therapy resistance
Over the past few decades, substantial evidence has convincingly revealed the existence of cancer stem cells (CSCs) as a minor subpopulation in cancers, contributing to an aberrantly high degree of cellular heterogeneity within the tumor. CSCs are functionally defined by their abilities of self-rene...
Autores principales: | Huang, Tianzhi, Song, Xiao, Xu, Dandan, Tiek, Deanna, Goenka, Anshika, Wu, Bingli, Sastry, Namratha, Hu, Bo, Cheng, Shi-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392012/ https://www.ncbi.nlm.nih.gov/pubmed/32754274 http://dx.doi.org/10.7150/thno.41648 |
Ejemplares similares
-
The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma
por: Goenka, Anshika, et al.
Publicado: (2021) -
The Role of Non-Coding RNAs in Glioma
por: Goenka, Anshika, et al.
Publicado: (2022) -
DNA damage and metabolic mechanisms of cancer drug resistance
por: Tiek, Deanna, et al.
Publicado: (2022) -
Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug-resistant gliomas
por: Tiek, Deanna M., et al.
Publicado: (2022) -
Unconventional Protein Secretion in Brain Tumors Biology: Enlightening the Mechanisms for Tumor Survival and Progression
por: Iglesia, Rebeca Piatniczka, et al.
Publicado: (2022)